Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer
Titel:
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer
Auteur:
Tolaney, Sara Burris, Howard Gartner, Elaina Mayer, Ingrid A. Saura, Cristina Maurer, Matthew Ciruelos, Eva Garcia, Agustin A. Campana, Frank Wu, Bin Xu, Yi Jiang, Jason Winer, Eric Krop, Ian